Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 AUROBINDO PHARMA   ADCOCK INGRAM
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-23
ADCOCK INGRAM
Jun-14
AUROBINDO PHARMA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs715331-   
Low Rs397238-   
Sales per share (Unadj.) Rs424.298.3-  
Earnings per share (Unadj.) Rs32.9-24.8-  
Cash flow per share (Unadj.) Rs54.1-20.5-  
Dividends per share (Unadj.) Rs3.000-  
Avg Dividend yield %0.50-  
Book value per share (Unadj.) Rs458.177.2-  
Shares outstanding (eoy) m585.94168.78-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.32.9 45.3%   
Avg P/E ratio x16.9-11.5 -147.2%  
P/CF ratio (eoy) x10.3-13.9 -74.1%  
Price / Book Value ratio x1.23.7 32.9%  
Dividend payout %9.10-   
Avg Mkt Cap Rs m325,75348,025 678.3%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m35,2233,014 1,168.6%   
Avg. sales/employee Rs Th03,866.4-  
Avg. wages/employee Rs Th0702.1-  
Avg. net profit/employee Rs Th0-974.2-  
INCOME DATA
Net Sales Rs m248,55416,598 1,497.5%  
Other income Rs m2,906116 2,500.0%   
Total revenues Rs m251,46016,715 1,504.4%   
Gross profit Rs m37,070-2,876 -1,288.8%  
Depreciation Rs m12,446716 1,737.3%   
Interest Rs m1,405450 312.4%   
Profit before tax Rs m26,125-3,926 -665.4%   
Minority Interest Rs m0-11 -0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6,849245 2,791.6%   
Profit after tax Rs m19,277-4,182 -460.9%  
Gross profit margin %14.9-17.3 -86.1%  
Effective tax rate %26.2-6.2 -419.5%   
Net profit margin %7.8-25.2 -30.8%  
BALANCE SHEET DATA
Current assets Rs m214,59912,157 1,765.2%   
Current liabilities Rs m114,9386,840 1,680.4%   
Net working cap to sales %40.132.0 125.2%  
Current ratio x1.91.8 105.1%  
Inventory Days Days21111 18.6%  
Debtors Days Days66124 52.9%  
Net fixed assets Rs m176,6687,086 2,493.1%   
Share capital Rs m58677 760.3%   
"Free" reserves Rs m267,8130-   
Net worth Rs m268,39913,028 2,060.2%   
Long term debt Rs m6,1904,578 135.2%   
Total assets Rs m392,12524,611 1,593.3%  
Interest coverage x19.6-7.7 -253.4%   
Debt to equity ratio x00.4 6.6%  
Sales to assets ratio x0.60.7 94.0%   
Return on assets %5.3-15.2 -34.8%  
Return on equity %7.2-32.1 -22.4%  
Return on capital %10.0-19.8 -50.6%  
Exports to sales %33.70-   
Imports to sales %15.30-   
Net fx Rs m44,0360-   
CASH FLOW
From Operations Rs m23,8681,417 1,684.6%  
From Investments Rs m-39,778-435 9,143.7%  
From Financial Activity Rs m18,1444,155 436.7%  
Net Cashflow Rs m2,2985,137 44.7%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.56 Rs / ZAR

Compare AUROBINDO PHARMA With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare AUROBINDO PHARMA With: PARNAX LAB  JUBILANT PHARMOVA   DIVIS LABORATORIES  MANKIND PHARMA  SAROJA PHARMA INDUSTRIES INDIA LTD.  



Today's Market

Gift Nifty Down 39 Points | Page Industries Q4 Results | ITC to Seek Demerger Approval | Top Buzzing Stocks Today Gift Nifty Down 39 Points | Page Industries Q4 Results | ITC to Seek Demerger Approval | Top Buzzing Stocks Today(Pre-Open)

Indian share markets continued the momentum as the session progressed and ended on firm footing.